Cargando…
Early Treatment with Pegylated Interferon Lambda for Covid-19
BACKGROUND: The efficacy of a single dose of pegylated interferon lambda in preventing clinical events among outpatients with acute symptomatic coronavirus disease 2019 (Covid-19) is unclear. METHODS: We conducted a randomized, controlled, adaptive platform trial involving predominantly vaccinated a...
Ejemplares similares
-
Effect of Early Treatment with Ivermectin among Patients with Covid-19
por: Reis, Gilmar, et al.
Publicado: (2022) -
Effect of early treatment with metformin on risk of emergency care and hospitalization among patients with COVID-19: The TOGETHER randomized platform clinical trial
por: Reis, Gilmar, et al.
Publicado: (2021) -
Effect of early treatment with fluvoxamine on risk of emergency care and hospitalisation among patients with COVID-19: the TOGETHER randomised, platform clinical trial
por: Reis, Gilmar, et al.
Publicado: (2022) -
Effect of Early Treatment With Hydroxychloroquine or Lopinavir and Ritonavir on Risk of Hospitalization Among Patients With COVID-19: The TOGETHER Randomized Clinical Trial
por: Reis, Gilmar, et al.
Publicado: (2021) -
Effect of a community health worker mHealth monitoring system on uptake of maternal and newborn health services in Rwanda
por: Hategeka, Celestin, et al.
Publicado: (2019)